1.61 USD
0.02
1.23%
Last update Dec 17, 1:44 PM EST
Main market
Day range
1.61
1.72
Previous close
1.63000
Open
1.61
Access this stock data via API
Subscribe
Estrella Immunopharma Inc.
1.61
0.02
1.23%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 4.1M 10.5M 1.4M 457.2K
Selling general and admin 3.2M 663.2K 296.2K 276.5K
Other operating expenses
Operating income -7.3M -11.1M -1.7M -733.7K
Non operating interest income
Income
Expense
Other income expense
Pretax income -7.3M -11.1M -1.7M -733.7K
Tax provision 1.6K 0 0 0
Net income -7.3M -11.1M -1.7M -733.7K
Basic EPS -0.3 -0.3 0.0 0.0
Diluted EPS -0.3 -0.3 0.0 0.0
Basic average shares 27.1M 35.2M 35.2M 35.2M
Diluted average shares 27.1M 35.2M 35.2M 35.2M
EBITDA -7.3M -11.1M -1.7M -733.7K
Net income from continuing op. -7.3M -11.1M -1.7M -733.7K
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 58 minutes

15:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).